In the latest vote of confidence that cellular immunotherapy is going to live up to its potential for transforming the way cancer is treated, this week Gilead Sciences purchased Kite Pharma, a leader in the development of chimeric antigen receptor (CAR) T cells, for $11.9 billion dollars.
About Us
In Vitro Technologies Life Sciences division has a long history of supporting the Australian research community reaching back to 1958 and has developed a reputation for being one of the most dynamic and successful life science suppliers throughout Australia and New Zealand.
In Vitro Technologies are the premier supplier for cell biology and immunology research throughout Australia and New Zealand. Our range of cells, consumables, reagents, and laboratory equipment support your cell biology workflow in the fields of Cancer, Neuroscience, Immunology, Diabetes &Â Obesity, Cardiology, Pharmacology, and Drug Discovery. By partnering with world-class suppliers, In Vitro Technologies enables high quality, reproducible data, allowing researchers to accelerate discovery and publish high impact papers.
Â
All news
Latest News
Aug 24, 2017
Proteome Profilers for monitoring Host Response to infection
Proteome Profilerâ„¢ Antibody Arrays allow for the measurement of up to 119 proteins in a single sample.
Aug 9, 2017
ATCC® answers world health organization's call to arms in the race against antimicrobial resistance.
MANASSAS, VA (August 8, 2017) — ATCC, a global leader in biological materials development, management, and standards, in partnership with the Institute for Life Science Entrepreneurship (ILSE) and the ATCC...
Jul 14, 2017
See the new Minifors 2 at PEWS.
Join us at the Protein Expression Workshop meeting for a hands-on demonstration of the new Minifors 2 from Infors-HT and the new eve bioprocess control software.Â
